HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masashi Kanai Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

4/2024Response to capmatinib in a patient with neuroendocrine carcinoma of the gallbladder origin harboring MET amplification.
10/2010Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masashi Kanai Research Topics

Disease

51Neoplasms (Cancer)
04/2024 - 01/2004
21Biliary Tract Neoplasms (Biliary Tract Cancer)
03/2024 - 06/2011
20Pancreatic Neoplasms (Pancreatic Cancer)
09/2023 - 04/2008
8Stroke (Strokes)
10/2023 - 10/2016
6Stomach Neoplasms (Stomach Cancer)
01/2016 - 12/2002
4Disease Progression
03/2024 - 01/2010
4Neoplasm Metastasis (Metastasis)
02/2019 - 04/2014
4Colorectal Neoplasms (Colorectal Cancer)
07/2018 - 01/2008
3Lymphatic Metastasis
04/2024 - 04/2005
3Heart Failure
01/2023 - 03/2020
3Sarcopenia
10/2022 - 01/2021
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 10/2010
2COVID-19
01/2022 - 08/2021
2Myocardial Infarction
12/2021 - 06/2021
2Adenocarcinoma
10/2020 - 04/2018
2Colonic Neoplasms (Colon Cancer)
05/2020 - 01/2017
2Lung Neoplasms (Lung Cancer)
01/2018 - 04/2017
2Esophageal Neoplasms (Esophageal Cancer)
09/2017 - 06/2007
1Neuroendocrine Carcinoma
04/2024
1Thyroid Neoplasms (Thyroid Cancer)
03/2024
1Glioma (Gliomas)
03/2024
1Heart Diseases (Heart Disease)
11/2023
1Turcot syndrome
10/2023
1Microsatellite Instability
10/2023
1Malnutrition (Nutritional Deficiencies)
10/2023
1Hepatocellular Carcinoma (Hepatoma)
12/2022
1Teratoma (Teratoid Tumor)
12/2022
1Cholangiocarcinoma
11/2022
1Genetic Predisposition to Disease (Genetic Predisposition)
10/2022
1Bile Duct Neoplasms (Bile Duct Cancer)
10/2022
1Acinar Cell Carcinoma
10/2022
1Body Weight (Weight, Body)
01/2022
1Acquired Immunodeficiency Syndrome (AIDS)
01/2022
1Acute Kidney Injury (Acute Renal Failure)
12/2021
1Atrial Fibrillation
12/2021
1Frailty
05/2021
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
10/2020
1Chronic Kidney Failure (Chronic Renal Failure)
03/2020
1Diabetes Mellitus
03/2020

Drug/Important Bio-Agent (IBA)

19GemcitabineFDA Link
12/2023 - 04/2008
9Cisplatin (Platino)FDA LinkGeneric
12/2023 - 05/2012
8Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2023 - 01/2008
6CurcuminIBA
11/2022 - 07/2011
5Proteins (Proteins, Gene)FDA Link
03/2020 - 12/2002
4Leucovorin (Folinic Acid)FDA Link
01/2019 - 01/2008
4S 1 (combination)IBA
12/2016 - 04/2008
3Biomarkers (Surrogate Marker)IBA
11/2023 - 12/2019
3Oxygen (Dioxygen)IBA
11/2023 - 06/2021
3NivolumabIBA
10/2023 - 12/2015
3PlatinumIBA
10/2022 - 12/2015
3Formaldehyde (Formol)FDA Link
01/2022 - 05/2019
3ParaffinIBA
01/2022 - 05/2019
3Carcinoembryonic AntigenIBA
12/2020 - 04/2014
3C-Reactive ProteinIBA
10/2016 - 04/2014
3CarbohydratesIBA
11/2015 - 04/2014
3AntigensIBA
11/2015 - 04/2014
3Fluorouracil (Carac)FDA LinkGeneric
05/2012 - 01/2008
2Irinotecan (Camptosar)FDA LinkGeneric
04/2024 - 04/2009
2Clostridium perfringens epsilon-toxinIBA
11/2023 - 12/2021
2Immune Checkpoint InhibitorsIBA
10/2023 - 12/2019
2folfirinoxIBA
01/2023 - 11/2020
2DNA (Deoxyribonucleic Acid)IBA
11/2022 - 01/2022
2Circulating Tumor DNAIBA
11/2022 - 10/2022
2AfatinibIBA
01/2022 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
12/2020 - 01/2016
2CreatinineIBA
03/2020 - 10/2019
2Messenger RNA (mRNA)IBA
12/2010 - 12/2002
2Docetaxel (Taxotere)FDA Link
10/2010 - 06/2007
1Etoposide (VP 16)FDA LinkGeneric
04/2024
1Carboplatin (JM8)FDA LinkGeneric
04/2024
1capmatinibIBA
04/2024
1dabrafenibIBA
03/2024
1trametinibIBA
03/2024
1Poly Adenosine Diphosphate RiboseIBA
04/2023
1beta-Aminoethyl Isothiourea (AET)IBA
02/2023
1Sorafenib (BAY 43-9006)FDA Link
12/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2021
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
01/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2020
1GlucuronidesIBA
05/2020
1ProdrugsIBA
05/2020
1NF-kappa B (NF-kB)IBA
05/2020
1A-factor (Streptomyces)IBA
04/2020

Therapy/Procedure

35Drug Therapy (Chemotherapy)
04/2024 - 01/2004
21Therapeutics
04/2024 - 01/2004
9Genomic Medicine
04/2024 - 04/2019
5Neoadjuvant Therapy
12/2023 - 11/2017
5Activities of Daily Living (ADL)
10/2023 - 07/2018
5Precision Medicine
08/2022 - 05/2016
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
09/2023 - 05/2018
4Cardiac Rehabilitation
01/2023 - 03/2020
4Radiotherapy
11/2022 - 11/2017
3Length of Stay
02/2022 - 03/2020
3Hepatectomy
01/2015 - 06/2014
2Adjuvant Chemotherapy
02/2019 - 06/2014
2Chemoradiotherapy
09/2017 - 11/2015
1Braces
01/2022